Table 2 Characteristics of the included patients in this meta-analysis
From: Lamivudine therapy for chronic hepatitis B in children: a meta-analysis
Author | Year | Age | Sex (male%) | HBV DNA (log10) | HBeAg (+), % | ALT, U/L |
|---|---|---|---|---|---|---|
Jonas | 2002 | 8.67 | 64 | 6442.2a | NR | 286 |
Figlerowicz | 2005 | 11 | 66 | NR | 100 | 72 |
Zhang | 2011 | 11.59 | 56 | NR | 100 | 181 |
Luo | 2006 | 7.9 | 58 | NR | NR | NR |
Wang | 2014 | NR | NR | NR | NR | NR |
He | 2007 | 11a | 58 | 5.58 | 100 | 100 |
Feng | 2011 | 7.5 | 51 | NR | 100 | 150 |
Wang | 2012 | 11.2 | 52 | 6.54 | 100 | 248 |
Liu | 2006 | 12 | 50 | NR | 100 | NR |
Xu | 2004 | 5.6 | 46 | NR | 100 | 99 |
Wang | 2013 | 10.24 | NR | 6.79 | 100 | 202 |
Gao | 2002 | 13.5 | 74 | 5203.2a | 80 | 224 |
Yang | 2010 | 10.16 | NR | 6.77 | 95 | 202 |